Literature DB >> 15116633

Osteoporotic pertrochanteric hip fractures: management and current controversies.

Dean G Lorich1, David S Geller, Jason H Nielson.   

Abstract

The treatment of intertrochanteric hip fractures has evolved over the past 80 years because of a better understanding of fracture anatomy, application of biomechanical principles, and novel technologic advances. Surgical treatment of intertrochanteric hip fractures is the current standard of care, with short-term goals of fracture stabilization and early patient mobilization and the long-term objective of restoring patients to their previous level of independence and function. Treatment for stable intertrochanteric hip fractures includes use of percutaneous intramedullary devices and open reduction and internal fixation using a sliding hip screw. To date, none of these devices has shown any clear clinical advantage over the dynamic hip screw. Intramedullary fixation has multiple theoretical advantages for the treatment of unstable fracture patterns; however, it remains unclear if ultimate functional outcome warrants the added expense of such treatment. For patients with a reverse obliquity fracture pattern, the advantage of the intramedullary construct has been shown.

Entities:  

Mesh:

Year:  2004        PMID: 15116633

Source DB:  PubMed          Journal:  Instr Course Lect        ISSN: 0065-6895


  52 in total

1.  Are short femoral nails superior to the sliding hip screw? A meta-analysis of 24 studies involving 3,279 fractures.

Authors:  Henry Wynn Jones; Philip Johnston; Martyn Parker
Journal:  Int Orthop       Date:  2006-02-22       Impact factor: 3.075

2.  Is tip apex distance as important as we think? A biomechanical study examining optimal lag screw placement.

Authors:  Patrick Kane; Bryan Vopat; Wendell Heard; Nikhil Thakur; David Paller; Sarath Koruprolu; Christopher Born
Journal:  Clin Orthop Relat Res       Date:  2014-04-24       Impact factor: 4.176

3.  Short versus long intramedullary nails for treatment of intertrochanteric femur fractures (AO 31-A1 and AO 31-A2): a systematic review.

Authors:  Pernille Bovbjerg; Lonnie Froberg; Hagen Schmal
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-07-18

4.  Influence of fragment volume on stability of 3-part intertrochanteric fracture of the femur: a biomechanical study.

Authors:  Jung-Hoon Do; Yong-Sik Kim; Sung-Jae Lee; Myoung-Lae Jo; Suk-Ku Han
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-04-04

5.  How are peri-implant fractures below short versus long cephalomedullary nails different?

Authors:  L Henry Goodnough; Brett P Salazar; Jamie Furness; James E Feng; Malcolm R DeBaun; Sean T Campbell; Justin F Lucas; William W Cross; Philipp Leucht; Kevin D Grant; Michael J Gardner; Julius A Bishop
Journal:  Eur J Orthop Surg Traumatol       Date:  2020-09-09

Review 6.  Complications of hip fractures: A review.

Authors:  Pedro Carpintero; Jose Ramón Caeiro; Rocío Carpintero; Angela Morales; Samuel Silva; Manuel Mesa
Journal:  World J Orthop       Date:  2014-09-18

7.  Treatment of Intertrochanteric Fractures Using the Compression Hip Nail.

Authors:  Je-Min Yi; Kye Young Han; Keun Woo Kim; Chang Hyun Ryu
Journal:  Hip Pelvis       Date:  2014-09-29

8.  Usefulness of multi-detector CT in Boyd-Griffin type 2 intertrochanteric fractures with clinical correlation.

Authors:  Suk-Ku Han; Bae-Young Lee; Yong-Sik Kim; Nam-Yong Choi
Journal:  Skeletal Radiol       Date:  2009-09-08       Impact factor: 2.199

9.  Risk factors for mechanical failure of intertrochanteric fractures after fixation with proximal femoral nail antirotation (PFNA II): a study in a Southeast Asian population.

Authors:  Wei Zhang; Rex Premchand Antony Xavier; Joshua Decruz; Ying Dong Chen; Derek Howard Park
Journal:  Arch Orthop Trauma Surg       Date:  2020-04-15       Impact factor: 3.067

10.  Internal fixation of pertrochanteric fractures using DHS with a two-hole side-plate.

Authors:  Daniel Ríha; Jan Bartonícek
Journal:  Int Orthop       Date:  2010-08       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.